| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0009 |